Skip to content

Clinical trials

Dermatomyositis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatomyositis Clear all

181 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20023
20033
20041
20052
20064
20071
20084
20092
20105
20115
20121
20134
20147
20157
20163
20178
20188
20196
20206
202112
202213
202314
202417
202519
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed75
Recruiting47
Unknown status20
Terminated14
Active, not recruiting8
Not yet recruiting7
Enrolling by invitation5
Withdrawn4
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)8
National Institute of Environmental Health Sciences (NIEHS)6
Assistance Publique - Hôpitaux de Paris4
Chongqing Precision Biotech Co., Ltd4
Karolinska Institutet4
Pfizer4
The First Affiliated Hospital with Nanjing Medical University4
University Hospital, Strasbourg, France4
Duke University3
Novartis Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatomyositis181
Polymyositis67
Myositis51
Lupus Erythematosus, Systemic30
Scleroderma, Systemic27
Arthritis, Juvenile21
Arthritis, Rheumatoid20
Autoimmune Diseases17
Scleroderma, Diffuse14
Sjogren's Syndrome13

Trials

Showing 51 to 75 of 181. Each trial links to its page on Pharma Observatory.

81 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.